Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
18 Sep 2023
18 Sep 2023
Historique:
received:
21
08
2023
accepted:
11
09
2023
medline:
21
9
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
epublish
Résumé
In this study, novel VEGFR-2-targeting thiazolidine-2,4-dione derivatives with potential anticancer properties were designed and synthesized. The ability of the designed derivatives to inhibit VEGFR-2 and stop the growth of three different cancer cell types (HT-29, A-549, and HCT-116) was examined
Identifiants
pubmed: 37731835
doi: 10.1039/d3ra05689a
pii: d3ra05689a
pmc: PMC10508263
doi:
Types de publication
Journal Article
Langues
eng
Pagination
27801-27827Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts of interest to declare.
Références
Environ Sci Pollut Res Int. 2023 Jan;30(4):8928-8955
pubmed: 35460480
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2206-2222
pubmed: 35980113
Proteins. 1993 Dec;17(4):412-25
pubmed: 8108382
Cancer Res. 1988 Feb 1;48(3):589-601
pubmed: 3335022
Antivir Ther. 2023 Oct;28(5):13596535231199838
pubmed: 37669909
Tumour Biol. 2016 Mar;37(3):2871-7
pubmed: 26409447
Bioorg Med Chem. 2015 Oct 1;23(19):6497-509
pubmed: 26344591
J Immunol Methods. 1994 Sep 14;174(1-2):311-20
pubmed: 8083535
Int J Cancer. 2011 Mar 1;128(5):1045-56
pubmed: 20473929
Nat Rev Drug Discov. 2006 Oct;5(10):835-44
pubmed: 17016424
Chem Rev. 2021 Mar 24;121(6):3297-3351
pubmed: 32692162
Arch Pharm (Weinheim). 2022 Feb;355(2):e2100359
pubmed: 34862634
Bioorg Chem. 2020 Sep;102:104059
pubmed: 32653608
Adv Protein Chem Struct Biol. 2014;96:235-65
pubmed: 25443960
Cancer Biol Med. 2013 Dec;10(4):183-6
pubmed: 24349827
J Chem Theory Comput. 2021 Oct 12;17(10):6281-6291
pubmed: 34586825
Gynecol Oncol. 2014 Feb;132(2):496-505
pubmed: 24316305
Eur J Pharmacol. 2011 Oct 1;668(1-2):15-24
pubmed: 21722632
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000 Dec;62(6 Pt B):8438-48
pubmed: 11138145
J Ethnopharmacol. 2020 Jan 30;247:112256
pubmed: 31586690
Bioorg Med Chem Lett. 2004 Nov 1;14(21):5289-93
pubmed: 15454213
Molecules. 2022 Jul 19;27(14):
pubmed: 35889478
Sci Rep. 2022 Jul 27;12(1):12821
pubmed: 35896557
J Biomol Struct Dyn. 2023 Jan 8;:1-16
pubmed: 36617888
Molecules. 2022 Nov 09;27(22):
pubmed: 36431818
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1903-1917
pubmed: 35801403
Oncology (Williston Park). 2002 Feb;16(2):217-26, 229; discussion 230-2
pubmed: 11866137
Int Immunopharmacol. 2018 Dec;65:493-502
pubmed: 30391882
J Chem Inf Model. 2018 Nov 26;58(11):2178-2182
pubmed: 30351057
J Clin Oncol. 2013 Oct 10;31(29):3639-46
pubmed: 24002501
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2191-2205
pubmed: 35975321
Drugs. 2015 Apr;75(5):553-60
pubmed: 25795101
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1760-1782
pubmed: 34340610
Int J Mol Sci. 2022 Jun 21;23(13):
pubmed: 35805916
Clin Pharmacol Ther. 1995 Jul;58(1):1-14
pubmed: 7628176
Vasc Health Risk Manag. 2006;2(3):213-9
pubmed: 17326328
Biochem Biophys Res Commun. 2007 May 4;356(2):323-8
pubmed: 17367763
Clin Cancer Res. 2007 May 15;13(10):2825-30
pubmed: 17504979
Bioorg Chem. 2014 Oct;56:27-33
pubmed: 24927033
Int J Cancer. 2011 Jul 1;129(1):245-55
pubmed: 21170960
PLoS One. 2013 Jul 05;8(7):e68566
pubmed: 23861918
Eur J Med Chem. 2010 Nov;45(11):5420-7
pubmed: 20869793
RSC Adv. 2021 Aug 9;11(43):27027-27041
pubmed: 35480026
Bioorg Med Chem. 2010 Aug 1;18(15):5738-48
pubmed: 20621496
Proteins. 2007 May 15;67(3):569-78
pubmed: 17348026
RSC Adv. 2021 Oct 12;11(48):30315-30328
pubmed: 35493991
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1884-1902
pubmed: 35801486
Curr Opin Cell Biol. 2020 Apr;63:174-185
pubmed: 32114309
J Biomol Struct Dyn. 2023 Sep-Oct;41(16):7986-8001
pubmed: 36184591
Bioorg Chem. 2020 Jan;94:103422
pubmed: 31812261
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1587-1599
pubmed: 35637622
Cell Biol Toxicol. 2021 Jun;37(3):479-496
pubmed: 33070227
J Mol Graph Model. 2009 Jun-Jul;27(8):889-99
pubmed: 19264523
BMC Anesthesiol. 2019 Jul 9;19(1):127
pubmed: 31288745
J Mol Graph Model. 2009 Feb;27(6):751-8
pubmed: 19138543
Expert Opin Drug Discov. 2021 Nov;16(11):1233-1237
pubmed: 34165011
Int J Mol Sci. 2022 Jul 29;23(15):
pubmed: 35955547
Biochim Biophys Acta. 1963 Nov 8;77:383-93
pubmed: 14089413
Front Cell Dev Biol. 2020 Nov 16;8:599281
pubmed: 33304904
Comput Biol Chem. 2023 Oct;106:107928
pubmed: 37480629
J Med Chem. 2015 Feb 12;58(3):1053-63
pubmed: 25474320
Molecules. 2022 Aug 08;27(15):
pubmed: 35956997
J Med Chem. 2004 Aug 26;47(18):4463-70
pubmed: 15317458
Bioorg Med Chem. 2021 Sep 15;46:116384
pubmed: 34479065
J Cheminform. 2021 Sep 25;13(1):72
pubmed: 34563256
Eur J Pharmacol. 2018 May 5;826:106-113
pubmed: 29501870
Nucleic Acids Res. 2015 Jul 1;43(W1):W443-7
pubmed: 25873628
Toxicol Appl Pharmacol. 2008 Jan 15;226(2):161-8
pubmed: 17935746
J Biochem Mol Toxicol. 2021 Feb;35(2):e22638
pubmed: 33002289
Drug Discov Today. 2001 Apr 1;6(7):357-366
pubmed: 11267922
Int Immunopharmacol. 2009 Jan;9(1):70-9
pubmed: 18976720
Eur J Med Chem. 2011 Dec;46(12):6112-8
pubmed: 22014995
PLoS One. 2022 Sep 23;17(9):e0272362
pubmed: 36149902
J Chem Inf Model. 2006 Nov-Dec;46(6):2267-77
pubmed: 17125169
Cancer Sci. 2011 Jul;102(7):1374-80
pubmed: 21443688